Our People

Some of the key assignments in these areas handled and being handled by Bharati amongst others, cover the following:

• Advising Paramount Global on its exit from Viacom18 by selling its remaining 13.01% stake to Reliance Industries Limited (RIL) for ₹4,286 crores. As part of the larger transaction of USD 8.5 billion, RIL and The Walt Disney Company will form a joint venture that will merge the media undertaking of Viacom18 with Star India through a court-approved scheme of arrangement.
• Acted for Tata Capital Health Care Fund II, (TCHF II) in its primary and secondary investment in a dialysis chain Apex Kidney Care. TCHF II is a growth-oriented private equity fund focused on the healthcare and life sciences sector in India. TCHF II is sponsored by Tata Capital Ltd.
• Acted for a large investment fund in its secondary investment in Lenskart.
• Acted for Paramount Global in a strategic partnership between Reliance, Bodhi Tree Systems, to form one of the largest TV and digital streaming companies in India. The value of the deal was around USD 1.9 billion.
• Acted for a large investment fund in its primary investment in Delhivery.
• Acted for InterGlobe Enterprises in its shareholders’ dispute with the Rakesh Gangwal group in InterGlobe Aviation Limited (IndiGo airlines).
• Advised Creation Investments, in its investment in Vivriti Capital Private Limited, a non-banking financial company.
• Acted for OFB Tech Private Limited (OfBusiness), a unicorn company in India, in its fund raising for Series D investment round.
• Acted for Creation Investments India III, LLC (Creation), a majority shareholder in Vivriti Capital Private Limited (Vivriti), in an investment received from Lightstone Fund S.A. of Rs. 350 crores, by way of subscription to securities issued by Vivriti in the Series B round.
• Advised UPL Limited, in the acquisition by its wholly owned subsidiary UPL Corporation Limited (UPL Corp) of Arysta LifeScience Inc. and its subsidiaries for USD 4.2 billion.